Alembic Global Advisors is an independent equity research firm offering differentiated, experienced financial analysis on a variety of global industrial sectors. Our goal is to provide high quality, proprietary and actionable research into company, industry and broader macro trends on a truly global level.
Since its founding in 2009, Alembic has expanded from its core global chemical coverage to the aerospace & defense sector. Our analysts have been recognized by industry publications Institutional Investor, FT/Starmine and Extel.2 research analysts covering 35 companies across 3 industries (Chemicals and Aerospace & Defense). Our coverage list continues to grow as we remain focused on delivering our best-in-class research product.
Through our corporate access events we provide unique opportunities to meet with a select group of industry leaders, offering the chance to gain unique insights from people operating at the highest levels of their respective industries.
In addition to highly analytical deep dive research surrounding our specific equity coverage, we provide our macro view of each industry against the global backdrop of current events and how we see them shaping the future. We leverage our various areas of expertise to produce a collaborative cross-sector research product. This non-siloed approach allows us to maximize our areas of expertise, ultimately achieving a more dynamic and in-depth level of insight.
Not a client? Please contact Stephen Matthews – stephen.matthews@alembicglobal.com – to learn more about our research subscription offerings.
Access is limited to Alembic Global Advisors clients.
Key Points We’re updating our forecast post HEI’s 4QFY24 earnings release yesterday and we’re reiterating our Overweight rating on the shares. The stock was hit hard yesterday (-8.7%) on a ......
Key Points Technology and scale-up concerns mostly allayed while capital raised. Product commercialization in 2025 could result in the next leg up in PCT shares First major product commercialization announcement ......
Key Points We are terminating coverage of Elbit Systems (ESLT; previously rated Overweight) due to a change in research focus. Going forward, we will no longer maintain an investment rating ......
Key Points Consensus 2025 earnings estimates undemanding, in our view. Macro trends could propel significant medium-term earnings growth Earnings power on the back of recent acquisitions still underappreciated. Valuation highly ......
Key Points We are maintaining our Overweight rating on shares of AVAV post the firm’s 2QFY25 earnings report earlier this week. The shares fell Thursday on margin headwinds in 2Q, ......
Key Points We’re updating our forecast for TDG for the first time post its 4QFY24 earnings report. We’ve very modestly lowered our FY25/26 sales outlook on concerns over commercial aftermarket ......